Skip to main content
. 2015 Feb 19;112(7):1283–1290. doi: 10.1038/bjc.2014.406

Table 4. The subgroup analyses for patients with HBsAg negative: univariate logistic regression analyses.

Variable Gastric cancer group (n=480) No. (%) Control group (n=510) No. (%) OR 95% CI P-value
ABO blood group (A/B/AB/O)         0.59
O 189 (40.3) 214 (42.3) 1 Reference  
A 135 (28.8) 132 (26.1) 1.16 0.85–1.58 0.35
B 112 (23.9) 131 (25.9) 0.97 0.70–1.33 0.84
AB 33 (7.0) 29 (5.7) 1.29 0.75–2.20 9.35
History of chronic gastritis (no/yes) 414/66 (86.3/13.8) 491/19 (96.3/3.7) 4.12 2.43–6.98 <0.001
Family history of gastric cancer (no/yes) 451/29 (94.0/6.0) 506/4 (99.2/0.8) 8.13 2.84–23.32 <0.001
Smoking (never/past and/or current) 311/166 (65.2/34.8) 317/193 (62.2/37.8) 0.88 0.68–1.14 0.32
Alcohol consumption (never/past and/or current) 397/80 (83.2/16.8) 430/80 (84.3/15.7) 1.08 0.77–1.52 0.64
History of diabetes mellitus (no/yes) 444/36 (92.5/7.5) 483/27 (94.7/5.3) 1.45 0.87–2.43 0.16
HBsAg negative (A)         0.12
HBsAg negative and anti-HBc negative and anti-HBs negative 105 (21.9) 111 (21.8) 1 Reference  
HBsAg negative and anti-HBc negative and anti-HBs positive 231 (48.1) 241 (47.3) 1.01 0.73–1.40 0.93
HBsAg negative and anti-HBc positive and anti-HBs negative 51 (10.6) 36 (7.1) 1.50 0.91–2.48 0.12
HBsAg negative and anti-HBc positive and anti-HBs positive 93 (19.4) 122 (23.9) 0.81 0.55–1.18 0.27
HBsAg negative (B)         0.12
HBsAg negative and anti-HBc positive and anti-HBs negative 51 (10.6) 36 (7.1) 1 Reference  
HBsAg negative and anti-HBc negative and anti-HBs positive 231 (48.1) 241 (47.3) 0.68 0.43–1.08 0.10
HBsAg negative and anti-HBc positive and anti-HBs positive 93 (19.4) 122 (23.9) 0.54 0.33–0.89 0.02
HBsAg negative and anti-HBc negative and anti-HBs negative 105 (21.9) 111 (21.8) 0.67 0.40–1.10 0.12

Abbreviations: anti-HBc=antibody to hepatitis B core antigen; anti-HBs=antibody to hepatitis B surface antigen; CI=confidence interval; HBsAg=hepatitis B surface antigen; OR=odds ratio.